ReviewJournal of clinical medicine2020
Prevention of Venous Thromboembolism in 2020 and Beyond.
Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06989255 (A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Training Data Set for Research Purposes), which is not on this map. Cited by 103 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Training Data Set for Research Purposes (Image Processing and Analysis, AI Model Training).
Who cites it
103 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Antiplatelets match anticoagulants for VTE prevention after joint arthroplasty: a meta-analysis of randomized clinical trials.EFORT open reviews · 2026Pooled it
- Aspirin as a viable alternative to oral anticoagulants for VTE prevention after hip arthroplasty: a meta-analysis of randomized clinical trials.BMC surgery · 2025Pooled it
- The Role of Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Abdominopelvic Surgery for Cancer.Clinical journal of oncology nursing · 2025Pooled it
- Genetic association and causal inference between lung function and venous thromboembolism.Respiratory research · 2023Pooled it
- Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2021Pooled it
- Apixaban vs rivaroxaban for venous thromboembolism: a systematic review and meta-analysis.Internal and emergency medicine · 2026Review
- A nomogram for assessing the risk of deep vein thrombosis following surgery for pilon fractures.Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2026Article
- HERDOO2 rule to identify women with unprovoked venous thromboembolism who can discontinue anticoagulation: Can I use non-VIDAS D-dimer with 2 cut points?Research and practice in thrombosis and haemostasis · 2026Article
- Study on the effectiveness and accessibility of a CDR-based VTE quality control platform in county-level hospitals.BMJ open quality · 2026Article
- Article
- Smart Technology-Assisted Patient-Centered Management in Venous Thromboembolism: Pilot Study on Anticoagulation Adherence.JMIR formative research · 2026Article
- Endothelial Cell-Specific Molecule-1 (ESM1): An Endogenous Anticoagulant and Protective Factor in Venous Thrombosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Antithrombotic therapy at the end-of-life-continue or stop?Research and practice in thrombosis and haemostasis · 2026Review
- Treatment failure in patients with obesity with venous thromboembolism receiving truncated vs. recommended lead-in times with apixaban at an academic medical center.Journal of thrombosis and thrombolysis · 2026Article
- Predicting deep vein thrombosis risk in patients with knee fractures: a nomogram-based study.Perioperative medicine (London, England) · 2026Article
- Exploring the risk of venous thromboembolism in women with rheumatoid arthritis initiating menopausal hormone treatment in England.Rheumatology advances in practice · 2026Article
- Venous thromboembolism prophylaxis in postacute care units: a health record review.Research and practice in thrombosis and haemostasis · 2026Article
- When and How Grid-Based Information Management for VTE Prevention: Boundary Conditions and Configurational Pathways from a Mixed-Methods Study.Journal of multidisciplinary healthcare · 2026Article
- ThrombUS+ Project: Toward Wearable Continuous Point-of-Care Monitoring for Deep Vein Thrombosis of the Lower Limb.Computational and structural biotechnology journal · 2026Article
- IgA anti-β2-glycoprotein I as an independent risk factor in acute venous thromboembolism.Frontiers in immunology · 2026Article
43 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.